These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17561585)

  • 21. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
    Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
    Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of scintimammography as an additional test to conventional mammography in detection of breast cancer].
    Cwikła JB; Buscombe JR; Kolasińska AD; Holloway B; Hilson AJ
    Ginekol Pol; 2003 May; 74(5):362-70. PubMed ID: 12931463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative evaluation of 99mTc-MIBI and 99mTc-HMDP scintimammography for the diagnosis of breast cancer and its axillary metastases.
    Nishiyama Y; Yamamoto Y; Ono Y; Irie A; Yamauchi A; Satoh K; Ohkawa M
    Eur J Nucl Med; 2001 Apr; 28(4):522-8. PubMed ID: 11357504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scintimammography with 99mTc-MIBI and magnetic resonance imaging in the evaluation of breast cancer.
    Bagni B; Franceschetto A; Casolo A; De Santis M; Bagni I; Pansini F; Di Leo C
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1383-8. PubMed ID: 12910383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
    Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination and prediction of P-glycoprotein and multidrug-resistance-related protein expression in breast cancer with double-phase technetium-99m sestamibi scintimammography. Visual and quantitative analyses.
    Kim IJ; Bae YT; Kim SJ; Kim YK; Kim DS; Lee JS
    Oncology; 2006; 70(6):403-10. PubMed ID: 17237619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial evaluation of breast cancer using Tc-99m sestamibi scintimammography.
    Tiling R; Kessler M; Untch M; Sommer H; Linke R; Hahn K
    Eur J Radiol; 2005 Feb; 53(2):206-12. PubMed ID: 15664284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
    Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
    J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours.
    Palmedo H; Bender H; Grünwald F; Mallmann P; Zamora P; Krebs D; Biersack HJ
    Eur J Nucl Med; 1997 Sep; 24(9):1138-45. PubMed ID: 9283107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can scintimammography with (99m)Tc-MIBI identify multifocal and multicentric primary breast cancer?
    Cwikla JB; Buscombe JR; Holloway B; Parbhoo SP; Davidson T; McDermott N; Hilson AJ
    Nucl Med Commun; 2001 Dec; 22(12):1287-93. PubMed ID: 11711898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial.
    Palmedo H; Biersack HJ; Lastoria S; Maublant J; Prats E; Stegner HE; Bourgeois P; Hustinx R; Hilson AJ; Bischof-Delaloye A
    Eur J Nucl Med; 1998 Apr; 25(4):375-85. PubMed ID: 9553167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 99mTc-MIBI and 99mTc-MDP scintimammography for detecting breast carcinoma.
    Chen S; Liu W; Mao Y; Zhu W; Yao Z; Sun X; Xiu Y; Yin Y; Chen J
    Chin Med J (Engl); 2000 May; 113(5):400-3. PubMed ID: 11776092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of the usefulness of combined mammography and scintimammography in suspected primary breast cancer using ROC curves.
    Buscombe JR; Cwikla JB; Holloway B; Hilson AJ
    J Nucl Med; 2001 Jan; 42(1):3-8. PubMed ID: 11197976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Technetium-99m sestamibi scintimammography: the influence of histopathological characteristics, lesion size and the presence of carcinoma in situ in the detection of breast carcinoma.
    Howarth D; Sillar R; Clark D; Lan L
    Eur J Nucl Med; 1999 Nov; 26(11):1475-81. PubMed ID: 10552090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging.
    Palmedo H; Grünwald F; Bender H; Schomburg A; Mallmann P; Krebs D; Biersack HJ
    Eur J Nucl Med; 1996 Aug; 23(8):940-6. PubMed ID: 8753683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of technetium-99m sestamibi scintimammography and contrast-enhanced magnetic resonance imaging for the evaluation of indeterminate mammograms.
    Tiling R; Khalkhali I; Sommer H; Moser R; Meyer G; Willemsen F; Pfluger T; Tatsch K; Hahn K
    Eur J Nucl Med; 1997 Oct; 24(10):1221-9. PubMed ID: 9323262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Technetium-99m-sestamibi scintimammography for the detection of breast carcinoma: comparison between planar and SPECT imaging.
    Tiling R; Tatsch K; Sommer H; Meyer G; Pechmann M; Gebauer K; Münzing W; Linke R; Khalkhali I; Hahn K
    J Nucl Med; 1998 May; 39(5):849-56. PubMed ID: 9591588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between 99mTc-sestamibi scintimammography and X-ray mammography in the characterization of clusters of microcalcifications: a prospective long-term study.
    Grosso M; Chiacchio S; Bianchi F; Traino C; Marini C; Cilotti A; Manca G; Volterrani D; Roncella M; Rampin L; Marzola MC; Rubello D; Mariani G
    Anticancer Res; 2009 Oct; 29(10):4251-7. PubMed ID: 19846982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
    Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
    Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of (99m)Tc sestamibi scintigraphy in the evaluation of doxorubicin based chemotherapy response in patients with advanced breast cancer.
    Alonso O; Delgado L; Núñez M; Vargas C; Lopera J; Andruskevicius P; Sabini G; Gaudiano J; Musé IM; Roca R
    Nucl Med Commun; 2002 Aug; 23(8):765-71. PubMed ID: 12124482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.